ArticleClinical and translational medicine2021

Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis.

Dongkui Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.